# SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

> **NCT06191393** · NA · COMPLETED · sponsor: **Aptitude Medical Systems** · enrollment: 614 (actual)

## Conditions studied

- SARS-CoV-2 Infection
- Influenza A
- Influenza B

## Interventions

- **DIAGNOSTIC_TEST:** Aptitude Medical Systems Metrix COVID/Flu Test

## Key facts

- **NCT ID:** NCT06191393
- **Lead sponsor:** Aptitude Medical Systems
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-20
- **Primary completion:** 2024-03-03
- **Final completion:** 2025-03-11
- **Target enrollment:** 614 (ACTUAL)
- **Last updated:** 2025-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06191393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06191393, "SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06191393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*